封面
市场调查报告书
商品编码
1977874

全球居家检测市场规模、份额、趋势及成长分析报告(2026-2034)

Global At-Home Lab Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 117 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计到 2034 年,家庭检测市场规模将从 2025 年的 95 亿美元成长至 127.9 亿美元,2026 年至 2034 年的复合年增长率为 3.36%。

由于消费者对便利、私密的医疗保健解决方案的需求日益增长,全球居家检测市场正在快速扩张。诊断技术的进步使得在家检测糖尿病、高胆固醇、感染疾病和荷尔蒙失衡等疾病成为可能。人们对预防医学和数位健康平台的日益重视也是推动市场成长的主要因素。

关键成长要素包括远端医疗的普及、便捷的检体采集套装以及透过线上平台快速处理检测结果。消费者非常青睐无需前往诊所或实验室即可在家中进行检测的便利性。医疗保健成本的上涨和个人健康意识的增强进一步推动了市场需求。监管部门的核准和检测准确性的提高也增强了消费者的信心。

展望未来,与行动医疗应用和基于人工智慧的健康追踪系统的整合预计将对市场产生积极影响。快速检测技术的持续创新将扩大可检测疾病的范围。网路连线和医疗保健服务不断改善的新兴市场具有巨大的成长潜力。随着个人化医疗日益重要,居家检测预计将在全球范围内继续保持持续成长。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章:全球家庭检测市场:依检测类型划分

  • 市场分析、洞察与预测
  • 血糖检测套组
  • 传染病检查试剂盒
  • 检测套组
  • 胆固醇试纸
  • 药物滥用检测套组
  • 凝血监测测试
  • 其他测试类型

第五章:全球家庭检测市场:依通路划分

  • 市场分析、洞察与预测
  • 医院药房
  • 零售药局/药局
  • 网路药房

第六章 全球家庭检测市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第八章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Quest Diagnostics
    • LabCorp
    • Everlywell
    • LetsGetChecked
    • Pixel By LabCorp
    • MyHeritage
    • 23andMe
    • BioIQ
    • Teladoc Health
    • HealthLinkNow
简介目录
Product Code: VMR112113715

The At-Home Lab Testing Market size is expected to reach USD 12.79 Billion in 2034 from USD 9.50 Billion (2025) growing at a CAGR of 3.36% during 2026-2034.

The Global At-Home Lab Testing Market is expanding rapidly due to increasing consumer preference for convenient and private healthcare solutions. Advances in diagnostic technology have enabled individuals to conduct tests for conditions such as diabetes, cholesterol, infections, and hormonal imbalances from home. Growing awareness of preventive healthcare and digital health platforms is significantly driving market growth.

Key growth drivers include telehealth expansion, user-friendly sample collection kits, and faster result processing through online platforms. Consumers appreciate the convenience of home testing without visiting clinics or laboratories. Rising healthcare costs and increased focus on personal wellness are further supporting demand. Regulatory approvals and improved test accuracy are also strengthening consumer confidence.

Looking forward, the market is expected to benefit from integration with mobile health apps and AI-based health tracking systems. Continuous innovation in rapid testing technologies will expand the range of detectable conditions. Emerging markets with improving internet connectivity and healthcare access offer substantial growth potential. As personalized healthcare becomes more prominent, at-home lab testing is projected to witness sustained global expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Glucose Test Kits
  • Infectious Diseases Test Kits
  • Pregnancy Test Kits
  • Cholesterol Test Strips
  • Drugs of Abuse Test Kits
  • Coagulation Monitoring Tests
  • Other Test Types

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies/Drug Stores
  • Online Pharmacies

COMPANIES PROFILED

  • Quest Diagnostics, LabCorp, Everlywell, LetsGetChecked, Pixel by LabCorp, MyHeritage, 23andMe, BioIQ, Teladoc Health, HealthLinkNow
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL AT-HOME LAB TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Glucose Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Infectious Diseases Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Pregnancy Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Cholesterol Test Strips Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Drugs of Abuse Test Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Coagulation Monitoring Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Other Test Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL AT-HOME LAB TESTING MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Distribution Channel
  • 5.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Retail Pharmacies/Drug Stores Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL AT-HOME LAB TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By Distribution Channel
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By Distribution Channel
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By Distribution Channel
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By Distribution Channel
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By Distribution Channel
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL AT-HOME LAB TESTING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Quest Diagnostics
    • 8.2.2 LabCorp
    • 8.2.3 Everlywell
    • 8.2.4 LetsGetChecked
    • 8.2.5 Pixel By LabCorp
    • 8.2.6 MyHeritage
    • 8.2.7 23andMe
    • 8.2.8 BioIQ
    • 8.2.9 Teladoc Health
    • 8.2.10 HealthLinkNow